NASHVILLE, Tenn.–(BUSINESS WIRE)–Cyted Health today announced positive clinical validation data from DETECT-ME, a prospective, multicenter study of the EndoSign® Barrett’s Esophagus (BE) Test. Conducted at 18 U.S. clinical sites, the study compared Cyted’s non-endoscopic, methylation-based test directly against standard endoscopy and biopsy, using samples collected with the FDA 510(k)-cleared EndoSign® Cell Collection Device. The data was presented at the American College of Gastroenterology
